SCHEMBL8514838

SCHEMBL8514838

CC(C)(C)OC(=O)N1CCN(c2nccc(-c3ccc(O)c(C(C)(C)C)c3)n2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.51
TBK1 Q9UHD2 2/20 0.50
CHRNA7 P36544 1/20 0.50
DDB1 Q16531 1/20 0.47
CRBN Q96SW2 1/20 0.47
SMARCA2 P51531 1/20 0.46
SMARCA4 P51532 1/20 0.46
PBRM1 Q86U86 1/20 0.46
GPR119 Q8TDV5 6/20 0.45
MAPT P10636 1/20 0.43
CKS1B P61024 1/20 0.43
SKP1 P63208 1/20 0.43
SKP2 Q13309 1/20 0.43
FAAH O00519 1/20 0.43
PTPN11 Q06124 1/20 0.43
HSP90AA1 P07900 1/20 0.42
HSP90AB1 P08238 1/20 0.42
DYRK2 Q92630 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8515183 0.87 ACHE (0.48) ACHETBK1CHRNA7DDB1CRBN
SCHEMBL8515547 0.86 ACHE (0.47) ACHETBK1CHRNA7DDB1CRBN
SCHEMBL8514479 0.85 TBK1 (0.50) ACHETBK1CHRNA7DDB1CRBN
SCHEMBL3651086 0.84 ACHE (0.57) ACHETBK1CHRNA7DDB1CRBN
SCHEMBL8510921 0.84 TBK1 (0.49) ACHETBK1CHRNA7DDB1CRBN
SCHEMBL8515176 0.83 ACHE (0.47) ACHETBK1CHRNA7DDB1CRBN
SCHEMBL30718255 0.83 CFTR (0.58) ACHETBK1CHRNA7DDB1CRBN
SCHEMBL8514133 0.83 CKS1B (0.48) CRBNSMARCA2SMARCA4PBRM1GPR119
SCHEMBL27029498 0.83 CFTR (0.58) ACHETBK1CHRNA7DDB1CRBN
SCHEMBL3274585 0.82 ACHE (0.66) ACHETBK1CHRNA7DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012069852-A1 PHARMACEUTICAL COMPOUNDS AS INHIBITORS OF SPHINGOSINE KINASE ALMAC DISCOVERY LIMITED (GB) 2012-05-31 WO disclosed